Infinity to Participate in Three Conferences in September

Business Wirevia The Motley Fool
Updated

Infinity to Participate in Three Conferences in September

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NAS: INFI) will be participating in three conferences during September. On September 3, 2013, Infinity will participate in meetings at Citi's 8th Annual Biotech Conference in Boston, MA. Additionally, Infinity will provide an overview of its business at the following conferences:

Live audio webcasts of Infinity's presentations at the Morgan Stanley and Stifel healthcare conferences will be accessible from the "Investors/Media" section of the company's website, www.infi.com, and replays will be available for 30 days following each event.


About Infinity Pharmaceuticals, Inc.

Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at www.infi.com.



Infinity Pharmaceuticals, Inc.
Jaren Madden, 617-453-1336
Jaren.Madden@infi.com
http://www.infi.com

KEYWORDS: United States North America Massachusetts New York

INDUSTRY KEYWORDS:

The article Infinity to Participate in Three Conferences in September originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement